DrugDashboards

Market view

insulin degludec · Injection, Solution

13 marketed package NDCs · 3 active manufacturers

Most dispensed: 200 U/mL · Injection, Solution · #3 syringe, plastics/carton / 3 ml in 1 syringe, plastic · 100 U/mL · Injection, Solution · #1 vial, glass/carton / 10 ml in 1 vial, glass · 100 U/mL · Injection, Solution · #5 syringe, plastics/carton / 3 ml in 1 syringe, plastic

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price has fallen 59% in a year, to $11.37 per mL — and generics that get this cheap tend to get abandoned rather than defended.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$20.00$40.00$60.00Mar 2016Sep 202603companies actively selling

Latest · Sep 2026 — typical price $11.37 · middle half $9.61$16.40 · full range $9.02$22.74 · 6 products · 3 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per mLSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for insulin degludec, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • TresibaAug 19, 2026
    Price down
    NADAC $9.02718 → $9.02082 per unit (-0.07%)
  • TresibaAug 19, 2026
    Price down
    NADAC $9.03903 → $9.03696 per unit (-0.02%)
  • TresibaAug 19, 2026
    Price up
    NADAC $18.06134 → $18.07211 per unit (+0.06%)
  • TresibaJul 22, 2026
    Price up
    NADAC $9.02431 → $9.02718 per unit (+0.03%)
  • TresibaJul 22, 2026
    Price down
    NADAC $18.07117 → $18.06134 per unit (-0.05%)
  • TresibaJul 22, 2026
    Price down
    NADAC $9.04254 → $9.03903 per unit (-0.04%)

Same drug class

Other molecules FDA puts in Insulin Analog, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Insulin degludec in shortage right now?
No. FDA does not currently list Insulin degludec in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Insulin degludec?
5 companies have marketed Insulin degludec in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Insulin degludec cost?
The typical pharmacy pays about $11.37 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

Shortage reports for this molecule

  • Planned discontinuationInsulin Degludec, Injection, 10 mL Insulin Degludec vial (NDC 73070-400-11)Jul 21, 2025
  • Planned discontinuationInsulin Degludec, Injection, 3 mL Insulin Degludec 100 units/mL (U-100) FlexTouch® (NDC 73070-403-15)Jul 21, 2025
  • Planned discontinuationInsulin Degludec, Injection, 3 mL Insulin Degludec 200 units/mL (U-200) FlexTouch® (NDC 73070-503-15)Jul 21, 2025

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.